Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!

Neurology

medtech-news-for-monteris-vesica-health-anaut-geneoscopy

Notizia - Recent Pharma, Healthcare and Biotech Happenings

Monteris Smallest Brain Laser Probe Launch; Vesica Health’s AssureMDx Test Launch; Anaut’s Eureka α Japanese Regulatory Approval; Geneoscopy’s Labcorp-Partnered Colon Cancer Test FDA Approval; Novel Omeza® OCM™ Diabetic Foot Ulcers Results; LEO Pharma Phase III Plaque Psoriasis Trial Results

Explore More...
evenamide-phase-ii-iii-trial-result

Evenamide (NW-3509): Advancing Solutions for Treatment-Resistant Schizophrenia

ulotaront-for-schizophrenia-treatment

Ulotaront (SEP-363856): A New Era in Schizophrenia Treatment

cvl-231-for-schizophrenia-treatment

A New Dawn: Emraclidine (CVL-231) and the Quest for Effective Schizophrenia Therapeutics

bristol-myers-squibb-karxt-emergent-4-trial

KarXT: Illuminating Pathways in Schizophrenia Treatment

rl-007-promise-for-cognitive-enhancement-in-schizophrenia

Beyond Symptom Management: RL-007’s Promise for Cognitive Enhancement in Schizophrenia

lyn-005-in-schizophrenia-treatment

Breaking Boundaries: The Promise of LYN-005 in Schizophrenia Treatment

iclepertin-for-cias-treatment

Iclepertin: Bridging the Gap in CIAS Treatment – the Answer to an Unmet Need

brilaroxazine-for-schizophrenia

Hope on the Horizon: Brilaroxazine’s Promise for Schizophrenia Patients

fanapt-for-bipolar-disorder-treatment

Vanda Broadens its Reach to Bipolar Disorder Treatment Market With Fanapt Approval

medtech-news-for-c2dx- abbott- medtronic-nexalin

C2Dx’s Shaw Scalpel System; Texas Original’s RSO Gummies; Abbott’s Whole Blood Rapid Test FDA Clearance; Medtronic’s TAVR Device FDA Clearance; Nexalin’s Device Improved Symptoms; CYduct Diagnostics’ Positive Study Results

pharma-news-for-bms-orchard-madrigal-astrazeneca

Bristol Myers Squibb’ Karuna Therapeutics Buyout; Orchard Therapeutics’ Lenmeldy FDA Approval; Madrigal Pharmaceuticals’ Rezdiffra FDA Approval; AstraZeneca’s Acquisition of Amolyt Pharma; Prilenia’s Pridopidine EU Marketing Approval

MedTech News for Allumiqs, MangoRx, Ventris

Allumiqs and Prolytix’s Partnership; Setpoint Medical’s Neuroimmune Modulation Platform gets FDA Breakthrough Designation; MangoRx Launches ‘PRIME’ with FDA-approved TRT; SeaStar Medical Updates Quelimmune Commercial Launch; Ventris Medical Gains 510(k) for Amplify® Bone Graft Putty

MedTech News for Philips, Boston Scientific, Varian

Philips Teamed with SyntheticMR; BioPhotas’s Celluma Light Therapy; Boston Scientific’s AGENTTM Drug-Coated Balloon; Varian’s TrueBeam and Edge Radiotherapy Systems; Carthera’s Brain-Blood Barrier Trial; Prototype Device Effectively Treated Multiorgan Failure

Pharma News for GSK, Sanofi, Biogen, Artiva

Survodutide Phase II trial Shows Groundbreaking Results in Liver Disease; GSK Announces Positive Headline Results from EAGLE-1 Phase III Trial; Dupixent sBLA Accepted for FDA Priority Review; Biogen’s QALSODY Received Positive Opinion from CHMP; FDA Granted Orphan Drug Designation to Immune-Onc’s IO-202; Artiva Biotherapeutics’s AlloNK® in Lupus Nephritis

MedTech News for ResMed, Masimo, Viz.Ai, UroMems

Tandem’s Automated Insulin Patch Pump; ResMed’s Bilevel Sleep Respiratory Devices; Masimo’s First Over-The-Counter Fingertip Pulse Oximeter; Viz.Ai Algorithm for Quantifying Intracerebral Hemorrhage; Canary Medical’s Heart Sound Monitor; UroMems’ Smart Urinary Sphincter System

Pharma News for GSK, Gilead, CSL, CymaBay

GSK Receives FDA Fast Track Designation for Bepirovirsen; Gilead to Acquire CymaBay Therapeutics; CSL Announces Top-line Results from the Phase III AEGIS-II Trial; Ruxoprubart Scores FDA Orphan Drug Designation for PNH Treatment; CymaBay Announces FDA Acceptance of NDA and Priority Review for Seladelpar; Biogen Received European Commission Approval for SKYCLARYS

Subscribe to our Updates

DelveInsight is dedicated to safeguarding your data. We ensure that your information is handled in compliance with relevant data privacy legislation, our internal guidelines, and our privacy policy.

Receive recent Healthcare updates directly in your inbox.

Days
loader